Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Raltegravir readily crosses the placenta to the fetus with maternal use during pregnancy. After birth, neonatal raltegravir elimination is highly variable and often extremely prolonged, with some neonates demonstrating rising profiles after birth despite removal from the source of extrinsic raltegra...

Descripción completa

Detalles Bibliográficos
Autores principales: Lommerse, Jos, Clarke, Diana, Kerbusch, Thomas, Merdjan, Henri, Witjes, Han, Teppler, Hedy, Mirochnick, Mark, Acosta, Edward P., Wenning, Larissa, Nachman, Sharon, Chain, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765695/
https://www.ncbi.nlm.nih.gov/pubmed/31215170
http://dx.doi.org/10.1002/psp4.12443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765695/
https://www.ncbi.nlm.nih.gov/pubmed/31215170
http://dx.doi.org/10.1002/psp4.12443

Ejemplares similares